Biolab plans US entry
Biolab vai entrar nos Estados Unidos
Intel ID : 234062
| Synopsis |
|
Biolab, a drug manufacturer based in São Paulo, will enter the United States market, as published by newspaper Estadão on 21 February 2016, citing Drummond's lawyer and partner, Pedro Drummond. According to the news, the company opened an office in Miami to look for business, and hired Drummond consulting firm as an adviser for this operation, the United States entry.
(content in portuguese)
A Biolab, fabricante de medicamentos com sede em São Paulo, vai entrar nos Estados Unidos, segundo publicou o Estadaõ em 21 de fevereiro de 2016, citando ao advogado e sócio da empresa Drummond, Pedro Drummond. De acordo com a notícia, a empresa já abriu um escritório em Miami para prospecção de negócios e contratou a consultora Drummond como assessora para a operação de entrar no mercado norte-americano. |
|
||||
| Intel ID | 234062 | |
| Value | ND | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Biolab
(31 Dec 2018) |
Revenue: EUR 262,14m EBITDA: EUR 47,18m Exchange Rate: 
|
|
| Date |
|
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Other
| Parties | Advisor | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|
|
|
- |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.